1. Home
  2. MMYT vs ARQT Comparison

MMYT vs ARQT Comparison

Compare MMYT & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MakeMyTrip Limited

MMYT

MakeMyTrip Limited

N/A

Current Price

$40.23

Market Cap

3.8B

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$23.61

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMYT
ARQT
Founded
2000
2016
Country
India
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.3B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
MMYT
ARQT
Price
$40.23
$23.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$106.33
$34.00
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
N/A
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$17.55
$34.46
Revenue Next Year
$17.65
$29.77
P/E Ratio
$107.67
N/A
Revenue Growth
N/A
91.34
52 Week Low
$32.67
$11.86
52 Week High
$113.85
$31.77

Technical Indicators

Market Signals
Indicator
MMYT
ARQT
Relative Strength Index (RSI) 35.90 47.78
Support Level $32.67 $22.56
Resistance Level $103.66 $23.46
Average True Range (ATR) 2.83 0.95
MACD 0.62 0.28
Stochastic Oscillator 51.34 61.18

Price Performance

Historical Comparison
MMYT
ARQT

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: